cipla ltd costs rupees strength likely to weigh on profit cipla ltd s profit is likely to be lower in the current fiscal year hurt by higher input costs and a stronger rupee the chairman of the indian pharmaceuticals company said "appreciation in the value of the indian rupee against foreign currencies has adversely affected both the rupee turnover and the profitability of the company " chairman y k hamied said at the annual general meeting exports make up almost of ciplas revenue cipla supplies finished drugs and drug ingredients to several u s generic drug makers 
